Seminars in Nuclear Medicine
Volume 39, Issue 1 , Pages 2-10 , January 2009

Clinically Proven Radiopharmaceuticals for Infection Imaging: Mechanisms and Applications

  • Stanley J. Goldsmith, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Stanley J. Goldsmith, MD, Director of Nuclear Medicine, Professor of Radiology and Medicine, New York-Presbyterian Hospital/Weill Cornell Medical Center, 525 East 68th Street, STARR-221, New York, NY 10021
    • ,
  • Shankar Vallabhajosula, PhD

References 

  1. Collins T. Acute and chronic inflammation. In:  Cotron RS,  Kumar V,  Collins T editor. Pathologic Basis of Disease. 6. Philadelphia: Saunders; 1999;p. 50–88
  2. Elgazzar AH, Elmonayeri M. Inflammation. In:  Elgazzar AH editors. The Pathophysiologic Basis of Nuclear Medicine. 2. Berlin: Springer-Verlag; 2006;p. 67–89
  3. Ranklin JA. Biologic mediators of acute inflammation. Clin Issues. 2004;15:3–17
  4. Wazir JF, Ansari NA. Pneumocystis carinii infection (Update and review). Arch Pathol Lab Med. 2004;128:1023–1027
  5. Lee DP, Waldvogel FA. Osteomyelitis. Lancet. 2004;364:369–379
  6. Vallabhajosula S. Technetium-99m-labeled chemotactic peptides: Specific for infection imaging?. J Nucl Med. 1997;38:1322–1326
  7. Vallabhajosula S, Harwig JF, Siemsen JK, et al. Radiogallium localization in tumors: Blood binding and transport and the role of transferrin. J Nucl Med. 1980;21:650–656
  8. Vallabhajosula S, Harwig JF, Wolf W. The mechanism of tumor localization of 67Ga-citrate: Role of transferring binding and the effect of tumor pH. Int J Nucl Med Biol. 1981;8:363–370
  9. Goldsmith SJ, Palestro CJ, Vallabhajosula S. Infectious diseases. In:  Wagner HN,  Szabo Z,  Buchanan JW editor. Principles of nuclear medicine. 2 ed. Philadelphia: Saunders; 1995;p. 729–745
  10. Weiner RE, Hoffer PB, Thakur ML. Lactoferrin: Its role as a Ga-67 binding protein from polymorphonuclear leukocytes. J Nucl Med. 1981;22:32–37
  11. Bleeker-Rovers CP, Vos FJ, Corstens FHM. Scintigraphic detection of infection and Inflammation. In:  Biersack HJ,  Freeman LM editor. Clinical Nuclear Medicine. Berlin: Springer; 2007;p. 347–359
  12. Rubin RH, Fishman AJ. The use of radiolabeled non-specific immunoglobulin in the detection of local inflammation. Semin Nucl Med. 1994;24:169–179
  13. Liberatore M, Clemente M, Lurilli AP, et al. Scintigraphic evaluation of disease activity in rheumatoid arthritis: A comparison of Tc-99m human non-specific immunoglobulin, leukocytes and albumin nanocolloids. Eur J Nucl Med. 1992;19:853–857
  14. Oyen WJ, Claessens RA, Raemakers JM, et al. Diagnosing infection in febrile granulocytopenic patients with In-111 labeled human immunoglobulin G. J Clin Oncol. 1992;10:61–68
  15. Nelson CA, Wang JQ, Leav I, et al. The interaction among glucose transport, hexokinase and glucose 6-phosphate with respect to 3H-2-deoxyglucose retention in murine tumor models. Nucl Med Biol. 1996;23:533–541
  16. Yamada S, Kubota K, Kubota R, et al. High accumulation of F-18 fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med. 1995;36:1301–1306
  17. Gutowski TD, Fisher SJ, Moon S, et al. Experimental studies of [18F]-2-fluoro-2-deoxyglucose (FDG) in infection and reactive lymph nodes. J Nucl Med. 1992;33:925
  18. Sugawara Y, Gutowski TD, Fisher SJ, et al. Uptake of positron emission tomography tracers in experimental bacterial infections: A comparative biodistribution study of radiolabeled FDG, thymidine, L-methionine, 67Ga-citrate. Eur J Nucl Med. 1999;26:333–341
  19. Bleeker-Rovers CP, Vos FJ, Muddle AH, et al. A prospective multicenter study of the value of FDG-PET as a part of structured diagnostic protocol in patients with fever of unknown origin. Eur J Nucl Med Mol Imaging. 2007;34:694–703
  20. McAfee JG, Thakur ML. Survey of radioactive agents for in vitro labeling of phagocytic leukocytes: 1 (Soluble agents). J Nucl Med. 1976;17:480–487
  21. Datz FL. In-111 labeled leukocytes for the detection of infection: current status. Semin Nucl Med. 1994;24:92–109
  22. Peters AM. The utility of 99mTc-HMPAO leukocytes for imaging infection. Semin Nucl Med. 1994;24:110–127
  23. Becker W, Borst U, Fischbach W, et al. Kinetic data of in vivo labeled granulocytes in humans with a murine Tc-99m labeled antibody. Eur J Nucl Med. 1989;15:361–366
  24. Klett R, Kordell J, Stahl U, et al. Immunoscintigraphy of septic loosening of knee endoprosthesis: a retrospective evaluation of the antigranulocyte antibody BW 250/183. Eur J Nucl Med Mol Imaging. 2003;20:1463–1466
  25. Barron B, Hanna C, Passalaqua AM, et al. LeukoScan Appendicitis Clinical Group Rapid diagnostic imaging of acute nonclassic appendicitis by leukoscintigraphy with sulesomab, a Tc-99m labeled antigranulocyte antibody Fab' fragment. Surgery. 1999;125:288–296
  26. Passalaqua AM, Klein RL, Wegener WA, et al. Diagnosing suspected acute nonclassic appendicitis with sulesomab, a radiolabeled antigranulocyte antibody imaging agent. J Pediatr Surg. 2004;39:1338–1344
  27. Gratz S, Schipper ML, Dorner J, et al: Leukoscan for imaging infection in different clinical settings: a retrospective evaluation and extended review of the literature. Clin Nucl Med 28:267-276
  28. Delcourt A, Huglo D, Prangere T, et al. Comparison between Leukoscan (Sulesomab) and Ga-67 for the diagnosis of osteomyelitis in the diabetic foot. Diabetes Metab. 2005;31:125–133
  29. Thakur ML, Richard MD, White FW. Monoclonal antibodies as agents for selective radiolabeling of human neutrophils. J Nucl Med. 1988;29:1817–1825
  30. Thakur ML, Marcus CS, Kipper SL, et al. Imaging infection with LeuTech. Nucl Med Commun. 2001;22:513–519
  31. Kipper SL, Rypins EB, Evans DG, et al. Neutrophil-specific 99mTc-labeled anti-CD-15 monoclonal antibody imaging for diagnosis of equivocal appendicitis. J Nucl Med. 2000;41:449–455
  32. Solanki KK, Bomanji J, Siraj Q, et al. Tc-99m “infecton”: A new class of radiopharmaceutical for imaging infection. J Nucl Med. 1993;34:11P
  33. Vinayamuri S, Hall AV, Solanki KK, et al. Comparison of 99mTc-infecton with radiolabeled white-cell imaging in the evaluation of bacterial infection. Lancet. 1996;347:233–235
  34. Britton KE, Wareham DW, Das SS, et al. Imaging bacterial infection with 99mTc-ciprofloxacin (Infecton). J Clin Pathol. 2002;55:817–823
  35. De Winter F, Gemmel F, Van Laere K, et al. 99mTc-ciprofloxacin planar and tomographic imaging for the diagnosis of infection in the post operative spine: Experience in 48 patients. Eur J Nucl Med Mol Imaging. 2004;31:233–239
  36. Sarda L, Cremieux AC, Lebellec Y, et al. Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J Nucl Med. 2003;44:920–926
  37. Signore A, Chianelli M, Annovazi A, et al. 123I-interleukin-2 scintigraphy for in vivo assessment of interstitial mononuclear cell infiltration in Crohn's disease. J Nucl Med. 2000;41:242–249
  38. Procaccini E, Chianelli M, Pantano P, et al. Imaging of autoimmune disease. Q J Nucl Med. 1999;43:100–112
  39. Rennen HJ, Boerman OC, Oyen WJ, et al. Kinetics of 99mTc-labeled interleukin-8 in experimental inflammation and infection. J Nucl Med. 2003;44:1502–1509
  40. Bleeker-Rovers CP, Rennen HJJM, Boerman OC, et al. 99mTc-labeled interleukin-8 for the scintigraphic detection of infection and inflammation. J Nucl Med. 2007;48:337–343

PII: S0001-2998(08)00099-8

doi: 10.1053/j.semnuclmed.2008.08.002

Seminars in Nuclear Medicine
Volume 39, Issue 1 , Pages 2-10 , January 2009

Article Tools

* Image Usage & Resolution